TEM Tempus Receives FDA clearance for pulmonary hypertension AI from ECG
TEM Tempus says it receives FDA clearance for its AI product intended to detect signs of pulmonary hypertension from standard ECGs.
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.